Leukotriene Signaling in Atherosclerosis and Ischemia : Phospholipase, inflammation and cardiovascular diseaseBÄCK, Magnus.Cardiovascular drugs and therapy. 2009, Vol 23, Num 1, pp 41-48, issn 0920-3206, 8 p.Article

Leukotriene receptors in atherosclerosisBÄCK, Magnus; HANSSON, Göran K.Annals of medicine (Helsinki). 2006, Vol 38, Num 7, pp 493-502, issn 0785-3890, 10 p.Article

Receptor preferences of cysteinyl-leukotrienes in the guinea pig lung parenchymaSAKATA, Kiyoto; BÄCK, Magnus.European journal of pharmacology. 2002, Vol 436, Num 1-2, pp 119-126, issn 0014-2999Article

Inhibitors of the 5-Lipoxygenase Pathway in AtherosclerosisBÄCK, Magnus.Current pharmaceutical design (Print). 2009, Vol 15, Num 27, pp 3116-3132, issn 1381-6128, 17 p.Article

Matrix Metalloproteinases in AtherothrombosisBÄCK, Magnus; KETELHUTH, Daniel F. J; AGEWALL, Stefan et al.Progress in cardiovascular diseases. 2010, Vol 52, Num 5, pp 410-428, issn 0033-0620, 19 p.Article

Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxibBÄCK, Magnus; LI YIN; INGELSSON, Erik et al.European heart journal. 2012, Vol 33, Num 15, pp 1928-1933, issn 0195-668X, 6 p.Article

The contractile action of leukotriene B₄ in the guinea-pig lung involves a vascular componentSAKATA, Kivoto; DAHLEN, Sven-Erik; BÄCK, Magnus et al.British journal of pharmacology. 2004, Vol 141, Num 3, pp 449-456, issn 0007-1188, 8 p.Article

An alternative pathway for metabolism of leukotriene D₄: effects on contractions to cysteinyl-leukotrienes in the guinea-pig tracheaBÄCK, Magnus; KUMLIN, Maria; COTGREAVE, Ian A et al.British journal of pharmacology. 2001, Vol 133, Num 7, pp 1134-1144, issn 0007-1188Article

5-lipoxygenase-activating protein : A potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammationBÄCK, Magnus; SULTAN, Ariane; OVCHINNIKOVA, Olga et al.Circulation research. 2007, Vol 100, Num 7, pp 946-949, issn 0009-7330, 4 p.Article

Leukotriene B₄ is an indirectly acting vasoconstrictor in guinea pig aorta via an inducible type of BLT receptorBÄCK, Magnus; HONG QIU; HAEGGSTRÖM, Jesper Z et al.American journal of physiology. Heart and circulatory physiology. 2004, Vol 56, Num 1, pp H419-H424, issn 0363-6135Article

Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular diseaseINGELSSON, Erik; LI YIN; BACK, Magnus et al.Journal of allergy and clinical immunology. 2012, Vol 129, Num 3, pp 702-707, issn 0091-6749, 6 p.Article

Cysteinyl leukotriene signaling through perinuclear CysLT₁ receptors on vascular smooth muscle cells transduces nuclear calcium signaling and alterations of gene expressionEATON, Alison; NAGY, Edit; PACAULT, Mathilde et al.Journal of molecular medicine (Berlin. Print). 2012, Vol 90, Num 10, pp 1223-1231, issn 0946-2716, 9 p.Article

Increased leukotriene concentrations in gingival crevicular fluid from subjects with periodontal disease and atherosclerosisBÄCK, Magnus; AIRILA-MANSSON, Stella; JOGESTRAND, Tomas et al.Atherosclerosis. 2007, Vol 193, Num 2, pp 389-394, issn 0021-9150, 6 p.Article

Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscleWALCH, Lawrence; NOREL, Xavier; BÄCK, Magnus et al.British journal of pharmacology. 2002, Vol 137, Num 8, pp 1339-1345, issn 0007-1188, 7 p.Article

Thromboxane synthase expression and thromboxane A₂ production in the atherosclerotic lesionGABRIELSEN, Anders; HONG QIU; HAEGGSTRÖM, Jesper Z et al.Journal of molecular medicine (Berlin. Print). 2010, Vol 88, Num 8, pp 795-806, issn 0946-2716, 12 p.Article

Les leucotriènes : des cibles thérapeutiques potentielles dans le traitement des maladies cardiovasculaires. Discussion = Leukotrienes : potential therapeutic targets in cardiovascular diseases. DiscussionBÄCK, Magnus; VACHERON, André; GODEAU, Pierre et al.Bulletin de l'Académie nationale de médecine. 2006, Vol 190, Num 7, pp 1511-1521, issn 0001-4079, 11 p.Article

Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbitsFOUDI, Nabil; NOREL, Xavier; RIENZO, Mario et al.American journal of physiology. Heart and circulatory physiology. 2009, Vol 66, Num 5, issn 0363-6135, H1882-H1888Article

Valvular osteoclasts in calcification and aortic valve stenosis severityNAGY, Edit; ERIKSSON, Per; YOUSRY, Mohamed et al.International journal of cardiology. 2013, Vol 168, Num 3, pp 2264-2271, issn 0167-5273, 8 p.Article

Increased urinary leukotriene E₄ excretion in obstructive sleep apnea: Effects of obesity and hypoxiaSTANKE-LABESQUE, Françoise; BÄCK, Magnus; LEFEBVRE, Blandine et al.Journal of allergy and clinical immunology. 2009, Vol 124, Num 2, pp 364-370, issn 0091-6749, 7 p.Article

Intermittent hypoxia-activated cyclooxygenase pathway: role in atherosclerosisGAUTIER-VEYRET, Elodie; ARNAUD, Claire; BÄCK, Magnus et al.The European respiratory journal. 2013, Vol 42, Num 2, pp 404-413, issn 0903-1936, 10 p.Article

Leukotriene Receptor Antagonism and the Prevention of Extracellular Matrix Degradation During Atherosclerosis and In-Stent StenosisHLAWATY, Hanna; JACOB, Marie-Paule; LOUEDEC, Liliane et al.Arteriosclerosis, thrombosis, and vascular biology. 2009, Vol 29, Num 4, pp 518-524, issn 1079-5642, 7 p.Article

Upregulation of the 5-Lipoxygenase Pathway in Human Aortic Valves Correlates With Severity of Stenosis and Leads to Leukotriene-Induced Effects on Valvular MyofibroblastsNAGY, Edit; ANDERSSON, Daniel C; CAIDAHL, Kenneth et al.Circulation (New York, N.Y.). 2011, Vol 123, Num 12, pp 1316-1325, issn 0009-7322, 10 p.Article